SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-21-000225
Filing Date
2021-11-15
Accepted
2021-11-15 09:02:00
Documents
43
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi-20210930x10q.htm   iXBRL 10-Q 1078721
2 EXHIBIT 31.1 atxi-20210930xex31d1.htm EX-31.1 12065
3 EXHIBIT 31.2 atxi-20210930xex31d2.htm EX-31.2 12044
4 EXHIBIT 32.1 atxi-20210930xex32d1.htm EX-32.1 5837
5 EXHIBIT 32.2 atxi-20210930xex32d2.htm EX-32.2 5862
  Complete submission text file 0001410578-21-000225.txt   3068939

Data Files

Seq Description Document Type Size
6 EX-101.SCH atxi-20210930.xsd EX-101.SCH 22522
7 EX-101.CAL atxi-20210930_cal.xml EX-101.CAL 17355
8 EX-101.DEF atxi-20210930_def.xml EX-101.DEF 106176
9 EX-101.LAB atxi-20210930_lab.xml EX-101.LAB 170513
10 EX-101.PRE atxi-20210930_pre.xml EX-101.PRE 148988
11 EXTRACTED XBRL INSTANCE DOCUMENT atxi-20210930x10q_htm.xml XML 305281
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 211406724
SIC: 2834 Pharmaceutical Preparations